GGrantIndex
Sort

53,477 grants matching addiction

Delineating the Externalizing Construct &Its Facets

$446,527
University Of Minnesota Twin Cities · R21 · FY2002 · MH

Different components of nicotine-induced upregulation of nicotinic receptors

$446,523
William N. Green · University Of Chicago · R01 · FY2014 · DA

Neuropharmacology of Ethanol Reinforcement

$446,502
George F Koob · Scripps Research Institute, The · R01 · FY2010 · AA

Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse

$446,497
Hedy Kober · Yale University · R01 · FY2019 · DA

Alaska Behavioral Health Aide Program: Formative research to evaluate a rural training and service delivery model to reduce disparities in AN/AI mental health and substance use disorders

$446,437
Stacy M. Rasmus · Northwest Indian College · S06 · FY2024 · GM

Maternal Opioid Treatment: Human Experimental Research

$446,433
Susan M Stine · Wayne State University · R01 · FY2006 · DA

Reinforcement Based Treatment for Pregnant Drug Abusers

$446,388
Margaret Smith Chisolm · Johns Hopkins University · R01 · FY2013 · DA

Decision-Making and Episodic Memory in Trajectories to Cannabis Addiction

$446,351
Raul Gonzalez · Florida International University · R01 · FY2012 · DA

OPIOIDS, OPIOID RECEPTORS, AND IMMUNE COMPETENCE

$446,297
Temple University · R01 · FY2000 · DA

Tobacco Smoking, Genes & Nicotinic Receptors

$446,288
Kelly P Cosgrove · Yale University · R01 · FY2008 · DA

APPSPIRE: expanding the reach of an innovative tobacco control program for youth

$446,282
Jeffery McLaughlin · Radiant Creative Group, Llc · R42 · FY2015 · DA

MOLECULAR EPIDEMIOLOGY OF ALCOHOLISM /COMORBID DISORDERS

$446,278
Washington University · P50 · FY2004 · AA

Clinical Relevance of Stress Neuroadaptation in Tobacco Dependence

$446,276
John J. Curtin · University Of Wisconsin-Madison · R01 · FY2012 · DA

Clinical Relevance of Stress Neuroadaptation in Tobacco Dependence

$446,276
John J. Curtin · University Of Wisconsin-Madison · R01 · FY2014 · DA

Role of Orexin in Cocaine Demand and Addiction

$446,255
Gary S. Aston-Jones · Rbhs-Robert Wood Johnson Medical School · R01 · FY2016 · DA

Counter Bias Training Simulation (CBTsim) Healthcare: A Novel Approach for Reducing the Impact of Implicit Bias on Healthcare Delivery

$446,193
Lois James · Washington State University · R01 · FY2023 · MD

Research Project 2: Modeling the Impact of Nicotine Regulation on Smoking and Smoking-Related Mortality

$446,166
David Mendez · University Of Michigan At Ann Arbor · U54 · FY2020 · CA

Project 3: Nicotine Product Claims on Appeal, Perceptions, and Use Behavior

$446,115
Darren M Mays · Ohio State University · U54 · FY2025 · CA

Development of PET radioligands for cerebral cannabinoid receptor (CB1)

$446,114
Andrew G Horti · Johns Hopkins University · R33 · FY2009 · MH

Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross

$446,100
Mohamad Imad Damaj · Virginia Commonwealth University · R01 · FY2020 · CA

The role of ENDS use in changing rates of escalation and quitting of cigarette smoking in those under age 35 years in US population

$446,068
John P Pierce · University Of California, San Diego · R01 · FY2018 · CA

Stress, Arousal and Mood: Affective Influences on Decisions under Uncertainty

$446,060
Elizabeth A. Phelps · Harvard University · R01 · FY2021 · DA

Cannabidiol and terpenoid interactions in amygdalar regulation of pain states

$446,030
Benjamin Land · University Of Washington · R01 · FY2023 · AT

Spatiotemporal Brain Imaging of Alcohol Effects on Inhibitory Control

$445,974
Ksenija Marinkovic · San Diego State University · R01 · FY2016 · AA

METHADONE AND BUPERNORPHINE: ANTE- AND POST-PARTUM

$445,908
Johns Hopkins University · R01 · FY2001 · DA